AGIO
AGIOS PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$33.07
−1.61%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- -$1.21
- Revenue estimate
- $52.7M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- -$1.69
- EPS estimate
- -$1.65
- Revenue actual
- $44.7M
- Revenue estimate
- $26.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +4.4%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $43
- PT range
- $32 – $55
- Analysts
- 6
4 Buy2 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | -$1.65 | -$1.69 | Miss -2.42% | $44.7M |
| Apr 29, 2026 | -$1.81 | -$1.69 | Beat 6.63% | $20.7M |
| Feb 12, 2026 | -$1.97 | -$1.86 | Beat 5.58% | $20.0M |
| Oct 30, 2025 | -$1.93 | -$1.78 | Beat 7.77% | $12.9M |
| Jul 31, 2025 | -$1.74 | -$1.93 | Miss -10.92% | $12.5M |
| May 1, 2025 | -$1.80 | -$1.55 | Beat 13.89% | $8.7M |
| Feb 13, 2025 | -$1.69 | -$1.74 | Miss -2.96% | $10.7M |
| Oct 31, 2024 | $17 | $4.20 | Miss -74.84% | $9.0M |
| Aug 1, 2024 | -$1.58 | -$1.69 | Miss -6.96% | $8.6M |
| May 2, 2024 | -$1.64 | -$1.45 | Beat 11.59% | $8.2M |
| Feb 15, 2024 | -$1.64 | -$1.72 | Miss -4.88% | $7.1M |
| Nov 2, 2023 | -$1.69 | -$1.64 | Beat 2.96% | $7.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026